OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 6
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 6
Showing 6 citing articles:
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 3
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 3
Unraveling the Immune Response Dynamics of Leishmaniasis: Insights, Challenges, and Vaccine Development
Angel A Justiz-Vaillant, Rodolfo Arozarena-Fundora, Shalini Pooransignh, et al.
(2024)
Open Access | Times Cited: 1
Angel A Justiz-Vaillant, Rodolfo Arozarena-Fundora, Shalini Pooransignh, et al.
(2024)
Open Access | Times Cited: 1
Unraveling the Immune Response Dynamics of Leishmaniasis: Insights, Challenges, and Vaccine Development
Angel A Justiz-Vaillant, Rodolfo Arozarena-Fundora, Darren Gopaul, et al.
(2024)
Open Access | Times Cited: 1
Angel A Justiz-Vaillant, Rodolfo Arozarena-Fundora, Darren Gopaul, et al.
(2024)
Open Access | Times Cited: 1
Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis
Marcos Ferrante, Bruna Martins Macedo Leite, Lívia Fontes, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 767-767
Open Access
Marcos Ferrante, Bruna Martins Macedo Leite, Lívia Fontes, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 767-767
Open Access
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dandan Shen, Yuelin Zhang, Xiang Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access
Dandan Shen, Yuelin Zhang, Xiang Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access
Determination of key hub genes in Leishmaniasis as potential factors in diagnosis and treatment based on a bioinformatics study
Mohsen Safaei, Arash Goodarzi, Zahra Abpeikar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Mohsen Safaei, Arash Goodarzi, Zahra Abpeikar, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
